Incorporating molecular tools into clinical trials and treatment for gliomas?

Abstract

PURPOSE OF REVIEW Knowledge of the molecular biology of gliomas may improve therapy. This review highlights several recent studies on this topic. RECENT FINDINGS Gliomas are the most common primary brain tumors in adults, and remain refractory to therapy despite decades of work. Discoveries in the last several years have led to a better understanding of… (More)

Topics

Cite this paper

@article{Lassman2007IncorporatingMT, title={Incorporating molecular tools into clinical trials and treatment for gliomas?}, author={Andrew B. Lassman and Eric C. Holland}, journal={Current opinion in neurology}, year={2007}, volume={20 6}, pages={708-11} }